Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Identifying New Antimigraine Targets: Lessons from Molecular Biology

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Novel Targeted Therapies for Inflammatory Bowel Disease

    Publikation: Bidrag til tidsskriftReviewpeer review

  3. Heteromeric α7β2 Nicotinic Acetylcholine Receptors in the Brain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Emerging migraine treatments and drug targets

    Publikation: Bidrag til tidsskriftReviewpeer review

  5. Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Proteome of fluid from human ovarian small antral follicles reveals insights in folliculogenesis and oocyte maturation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. N-acetylcysteine protects ovarian follicles from ischemia-reperfusion injury in xenotransplanted human ovarian tissue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Parental Acceptance Rate of Testicular Tissue Cryopreservation in Danish Boys with Cryptorchidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Biological and Clinical Rationale for Androgen Priming in Ovarian Stimulation

    Publikation: Bidrag til tidsskriftReviewpeer review

  • C Alviggi
  • R Marci
  • R Vallone
  • A Conforti
  • F Di Rella
  • I Strina
  • S Picarelli
  • P De Rosa
  • M De Laurentiis
  • C Yding Andersen
  • G De Placido
Vis graf over relationer

OBJECTIVE: To evaluate the hormonal profile in three breast cancer patients who underwent controlled ovarian stimulation in the presence of the aromatase inhibitor letrozole.

PATIENTS AND METHODS: In IVF University referral center, a case series of three breast cancer patients who underwent controlled ovarian stimulation (COS) with recombinant FSH and letrozole were investigated. Ovulation was induced with hCG (case No. 1) or with GnRH agonist (case No. 2-3). The primary outcome of our study was the detection of progesterone levels in the luteal phase.

RESULTS: Very high progesterone values (mean 186.6 ± 43.6 ng/mL) during the luteal phase were recorded in all three cases.

CONCLUSIONS: High progesterone levels can be related to the use of letrozole independently of the most commonly used trigger regimen. Although progesterone has long been considered a protective factor against breast cancer, several studies have demonstrated that progesterone could expand a transformation-sensitive stem cell population in the mammary glands. The estrogen negative feedback effect on the hypothalamus-pituitary axis and the disruption of steroid biosynthesis and could represent an intriguing reason behind this phenomenon. Our results highlight the need to evaluate further the increase in progesterone levels in the luteal phase in women with breast cancer undergoing COS with letrozole.

OriginalsprogEngelsk
TidsskriftTrends in Pharmacological Sciences
Vol/bind21
Udgave nummer13
Sider (fra-til)3134-3138
Antal sider5
ISSN0165-6147
StatusUdgivet - jul. 2017

ID: 52660885